$12.00 (-2.20%)

Volume: 237.563k

Closed: Jan 27, 2023

Hollow Logo Score: 2.707
Cara Therapeutics Stock
$12.00 (-2.20%)

Volume: 237.563k

Closed: Jan 27, 2023

Score Hollow Logo 2.707

Discuss Cara Therapeutics Stock

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Unlock All Premium Features! Go Premium! Only $19.90/Month

Unlock the Top 5 candidates in every list
Unlock full Ultimate List Builder
Golden Star lists & Auto Portfolios
Possible Runners & Moving Average lists
Ad-free browsing
Save data in PDF

Hot Stocks To Watch:

About Cara Therapeutics

Cara Therapeutics Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE